H.B. Fuller Makes Recommended Cash Offer To Acquire Advanced Medical Solutions At £2.85 Per Share, Implying £715M Enterprise Value, Expects ~$55M In Run-Rate Synergies

Benzinga Newsdesk www.benzinga.com Positive 95.1%

Neg 0% Neu 0% Pos 95.1%

Extends capabilities in attractive, high-growth medical segments
Accelerates portfolio mix shift and path to >20% EBITDA margin target
Expected to deliver ~$55 million in run-rate synergies

Comments

No comments yet. Be the first!